Bayer AG (BAYZF)
45.41
+1.61
(+3.68%)
USD |
OTCM |
May 20, 11:10
Bayer EPS Diluted (Quarterly) : 3.290 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck KGaA | 0.3547 |
| Dermapharm Holding SE | 0.9822 |
| Johnson & Johnson | 2.141 |
| Pfizer Inc. | 0.4688 |
| Astellas Pharma, Inc. | 0.1543 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.237B |
| Revenue (Quarterly) | 15.68B |
| Total Expenses (Quarterly) | 12.45B |
| Enterprise Value | 81.37B |
| Gross Profit Margin (Quarterly) | 60.97% |
| Profit Margin (Quarterly) | 20.64% |
| Earnings Yield | -5.58% |
| Operating Earnings Yield | 18.10% |
| Normalized Earnings Yield | 4.739 |